- Home
- CNI vs IDXX Comparison
CNI vs IDXX Comparison
Compare CNI & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNI
- IDXX
- Stock Information
- Founded
- CNI 1919
- IDXX 1983
- Country
- CNI Canada
- IDXX United States
- Employees
- CNI N/A
- IDXX N/A
- Industry
- CNI
- IDXX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CNI
- IDXX Health Care
- Exchange
- CNI Nasdaq
- IDXX Nasdaq
- Market Cap
- CNI 60.4B
- IDXX 52.5B
- IPO Year
- CNI N/A
- IDXX 1991
- Fundamental
- Price
- CNI $96.38
- IDXX $629.06
- Analyst Decision
- CNI Buy
- IDXX Buy
- Analyst Count
- CNI 14
- IDXX 8
- Target Price
- CNI $117.44
- IDXX $624.38
- AVG Volume (30 Days)
- CNI 1.7M
- IDXX 425.6K
- Earning Date
- CNI 10-31-2025
- IDXX 10-30-2025
- Dividend Yield
- CNI 1.87%
- IDXX N/A
- EPS Growth
- CNI N/A
- IDXX 19.17
- EPS
- CNI 5.32
- IDXX 12.01
- Revenue
- CNI $12,569,471,933.00
- IDXX $4,037,715,000.00
- Revenue This Year
- CNI $2.75
- IDXX $10.69
- Revenue Next Year
- CNI $4.64
- IDXX $8.23
- P/E Ratio
- CNI $17.98
- IDXX $52.55
- Revenue Growth
- CNI 0.63
- IDXX 6.68
- 52 Week Low
- CNI $91.07
- IDXX $356.14
- 52 Week High
- CNI $116.79
- IDXX $688.12
- Technical
- Relative Strength Index (RSI)
- CNI 60.62
- IDXX 47.72
- Support Level
- CNI $93.82
- IDXX $600.57
- Resistance Level
- CNI $94.77
- IDXX $642.25
- Average True Range (ATR)
- CNI 1.34
- IDXX 16.76
- MACD
- CNI 0.43
- IDXX -2.42
- Stochastic Oscillator
- CNI 96.59
- IDXX 46.84
About CNI Canadian National Railway Company
Canadian National's railway spans Canada from coast to coast and extends through Chicago to the Gulf of Mexico. In 2024, CN generated CAD 17 billion in revenue by hauling intermodal containers (22% of consolidated revenue), petroleum and chemicals (20%), grain and fertilizers (20%), forest products (11%), metals and minerals (12%), automotive shipments (5%), and coal (5%). Other items constitute the remaining revenue.
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.